› Home
› About us
› Investment philosophy
› Our portfolio
› Partnerships
›
News & events
› Contact
› Career opportunities
› Investor login
Forbion News
|
Archive
Forbion Capital Partners co-leads $20 Million Series A Financing of Exosome Diagnostics
05.17.2010
Forbion Capital Partners Leads € 10 M Series A Financing in Cardoz to Develop Drug for Aortic Aneurysm
05.10.2010
Forbion Capital Partners Opens German Office and Expands Team
03.16.2010
Portfolio Company News
|
Archive
AMT’s Marketing Authorisation Application for Glybera® Progressing On Schedule
08.18.2010
Argos Therapeutics’ Arcelis™ HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebound Kinetics in Interim Analysis of Phase 2 Study
08.05.2010
ARGEN-X GRANTED BROAD PATENT COVERING ITS UNIQUE SIMPLE ANTIBODYT PLATFORM
07.15.2010
Events
You can meet the Forbion team at one of the following events:
Therapeutic antibodies and beyond: celebrating 20 years of display technologies
»
Cambridge, UK:
09.06.2010 - 09.07.2010
10th Annual Biotech in Europe Investor Forum
»
Zurich, Switzerland:
09.29.2010 - 09.30.2010
Jefferies 2010 Global SpecPharma & European Healthcare Conference
»
London, UK:
10.05.2010 - 10.06.2010
BioPartnering Europe 2010
»
London, UK:
10.11.2010 - 10.12.2010
Bio-Europe 2010
»
Munich, Germany:
11.15.2010 - 11.17.2010
SuperInvestor 2010
»
Paris, France:
11.16.2010 - 11.19.2010
© Forbion 2010 All rights reserved